BIOMARKERS

Molecular Biopsy of Human Tumors

- a resource for Precision Medicine *

318 related articles for article (PubMed ID: 26861646)

  • 1. Lipoprotein Like Nanoparticles Used in Drug and Gene Delivery.
    Varshosaz J; Vakilzadeh H; Ghassami E
    Curr Pharm Des; 2016; 22(22):3466-85. PubMed ID: 26861646
    [TBL] [Abstract][Full Text] [Related]  

  • 2. Hollow Inorganic Nanoparticles as Efficient Carriers for siRNA Delivery: A Comprehensive Review.
    Varshosaz J; Taymouri S
    Curr Pharm Des; 2015; 21(29):4310-28. PubMed ID: 26323421
    [TBL] [Abstract][Full Text] [Related]  

  • 3. Nanoparticles for targeted delivery of therapeutics and small interfering RNAs in hepatocellular carcinoma.
    Varshosaz J; Farzan M
    World J Gastroenterol; 2015 Nov; 21(42):12022-41. PubMed ID: 26576089
    [TBL] [Abstract][Full Text] [Related]  

  • 4. Synthetic lipoprotein as nano-material vehicle in the targeted drug delivery.
    Zhang X; Huang G
    Drug Deliv; 2017 Dec; 24(sup1):16-21. PubMed ID: 29069931
    [TBL] [Abstract][Full Text] [Related]  

  • 5. Native and Reconstituted Plasma Lipoproteins in Nanomedicine: Physicochemical Determinants of Nanoparticle Structure, Stability, and Metabolism.
    Pownall HJ; Rosales C; Gillard BK; Ferrari M
    Methodist Debakey Cardiovasc J; 2016 Sep; 12(3):146-150. PubMed ID: 27826368
    [TBL] [Abstract][Full Text] [Related]  

  • 6. Lipoproteins for therapeutic delivery: recent advances and future opportunities.
    Raut S; Dasseux JL; Sabnis NA; Mooberry L; Lacko A
    Ther Deliv; 2018 Mar; 9(4):257-268. PubMed ID: 29495929
    [TBL] [Abstract][Full Text] [Related]  

  • 7. Synthetic Lipoproteins as Carriers for Drug Delivery.
    Huang G; Liu Y; Huang H
    Curr Med Chem; 2016; 23(40):4601-4608. PubMed ID: 27781947
    [TBL] [Abstract][Full Text] [Related]  

  • 8. Lipoprotein-inspired nanoparticles for cancer theranostics.
    Ng KK; Lovell JF; Zheng G
    Acc Chem Res; 2011 Oct; 44(10):1105-13. PubMed ID: 21557543
    [TBL] [Abstract][Full Text] [Related]  

  • 9. [Recent development of natural and reconstituted lipoprotein based nano drug delivery vehicles].
    Xu Y; Jin XF; Ping QN; Liu HF; Chen M; Xu XM
    Yao Xue Xue Bao; 2014 Jan; 49(1):23-9. PubMed ID: 24783501
    [TBL] [Abstract][Full Text] [Related]  

  • 10. Artificial High Density Lipoprotein Nanoparticles in Cardiovascular Research.
    Kornmueller K; Vidakovic I; Prassl R
    Molecules; 2019 Aug; 24(15):. PubMed ID: 31382521
    [TBL] [Abstract][Full Text] [Related]  

  • 11. Natural low- and high-density lipoproteins as mighty bio-nanocarriers for anticancer drug delivery.
    Mahmoudian M; Salatin S; Khosroushahi AY
    Cancer Chemother Pharmacol; 2018 Sep; 82(3):371-382. PubMed ID: 29915981
    [TBL] [Abstract][Full Text] [Related]  

  • 12. Potential of Lipoprotein-Based Nanoparticulate Formulations for the Treatment of Eye Diseases.
    Fukuda R; Murakami T
    Biol Pharm Bull; 2020; 43(4):596-607. PubMed ID: 32238702
    [TBL] [Abstract][Full Text] [Related]  

  • 13. Nanoparticles Based on Plasma Proteins for Drug Delivery Applications.
    Tezcaner A; Baran ET; Keskin D
    Curr Pharm Des; 2016; 22(22):3445-54. PubMed ID: 26861647
    [TBL] [Abstract][Full Text] [Related]  

  • 14. Lipoprotein-Related and Apolipoprotein-Mediated Delivery Systems for Drug Targeting and Imaging.
    Almer G; Mangge H; Zimmer A; Prassl R
    Curr Med Chem; 2015; 22(31):3631-51. PubMed ID: 26180001
    [TBL] [Abstract][Full Text] [Related]  

  • 15. Tumor-targeted delivery of paclitaxel using low density lipoprotein-mimetic solid lipid nanoparticles.
    Kim JH; Kim Y; Bae KH; Park TG; Lee JH; Park K
    Mol Pharm; 2015 Apr; 12(4):1230-41. PubMed ID: 25686010
    [TBL] [Abstract][Full Text] [Related]  

  • 16. A Review on Natural Sources Derived Protein Nanoparticles as Anticancer Agents.
    Bhattacharya T; Maishu SP; Akter R; Rahman MH; Akhtar MF; Saleem A; Bin-Jumah M; Kamel M; Abdel-Latif MA; Abdel-Daim MM
    Curr Top Med Chem; 2021; 21(12):1014-1026. PubMed ID: 33845744
    [TBL] [Abstract][Full Text] [Related]  

  • 17. Advanced targeted therapies in cancer: Drug nanocarriers, the future of chemotherapy.
    Pérez-Herrero E; Fernández-Medarde A
    Eur J Pharm Biopharm; 2015 Jun; 93():52-79. PubMed ID: 25813885
    [TBL] [Abstract][Full Text] [Related]  

  • 18. Design and evaluation of lipoprotein resembling curcumin-encapsulated protein-free nanostructured lipid carrier for brain targeting.
    Meng F; Asghar S; Xu Y; Wang J; Jin X; Wang Z; Wang J; Ping Q; Zhou J; Xiao Y
    Int J Pharm; 2016 Jun; 506(1-2):46-56. PubMed ID: 27094357
    [TBL] [Abstract][Full Text] [Related]  

  • 19. Recent advances on biocompatible and biodegradable nanoparticles as gene carriers.
    Mokhtarzadeh A; Alibakhshi A; Yaghoobi H; Hashemi M; Hejazi M; Ramezani M
    Expert Opin Biol Ther; 2016 Jun; 16(6):771-85. PubMed ID: 26998622
    [TBL] [Abstract][Full Text] [Related]  

  • 20. Gelatin-based nanoparticles as drug and gene delivery systems: reviewing three decades of research.
    Elzoghby AO
    J Control Release; 2013 Dec; 172(3):1075-91. PubMed ID: 24096021
    [TBL] [Abstract][Full Text] [Related]  

    [Next]    [New Search]
    of 16.